Business
Cryo-Cell Receives NYSE American Continued Listing Notice
OLDSMAR, Fla., March 12, 2026--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that is has received a written notice (the "Notice") from the NYSE American LLC (the "NYSE American") stating that the Company is not in compliance with certain continued listing standards set forth in the NYSE American Company Guide.
About this update from Cryo-cell International, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/244933be5878b0319e51dc2313288854"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Exv0EGCePJynMR4D5OuNPA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/244933be5878b0319e51dc2313288854","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/WKaB9aOVe5uoHmuXUavoKg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/244933be5878b0319e51dc2313288854","width":1024,"height":512}},"lazy":false},{"type":"text","content":"OLDSMAR, Fla., March 12, 2026--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the "Company"), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that is has received a written notice (the "Notice") from the NYSE American LLC (the "NYSE American") stating that the Company is not in compliance with certain continued listing standards set forth in the NYSE American Company Guide.","length":479,"tagName":"p"},{"type":"text","content":"Specifically, the Notice indicated that the Company is not in compliance with Section 1003 (a) of the NYSE American Company Guide because the Company reported (i) a stockholders’ deficit as of November 30, 2025, and (ii) net losses in two of its three most recent fiscal years ended November 30, 2023, November 30, 2024 and November 30, 2025.","length":342,"tagName":"p"},{"type":"text","content":"The Notice has no immediate effect on the listing or trading of the Company’s common stock, which will continue to trade on the NYSE American under the symbol "CCEL" while the Company pursues a plan to regain compliance.","length":230,"tagName":"p"},{"type":"text","content":"In accordance with NYSE American requirements, the Company intends to submit a plan to regain compliance within the prescribed timeframe. If the plan is accepted, the Company is typically granted a period of up to 18 months from receipt of the Notice to regain compliance. During this period, the Company’s common stock will continue to be listed and traded on the NYSE American, subject to the Company’s co...